0
Biotechnology |

Development of a Novel Mobile Application to Support Self-Management in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Yeung Melanie, MHS; Joseph Cafazzo, PhD; Emily Seto, PhD; Kenneth Chapman, MD; Deborah Casey, MD
Author and Funding Information

Centre for Global eHealth Innovation, University Health Network, Toronto, ON, Canada


Chest. 2015;148(4_MeetingAbstracts):19A. doi:10.1378/chest.2271179
Text Size: A A A
Published online

Abstract

SESSION TITLE: 21st Century Technology

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Wednesday, October 28, 2015 at 08:45 AM - 10:00 AM

PURPOSE: Self-management is a key component of evidence-based care for patients living with COPD. Mobile-based applications with patient-specific information may support COPD patients in learning self-management skills, including adherence to inhaled medications, proper inhaler device technique, and early identification and response to acute exacerbations. There is currently no application with these features available to COPD patients in Canada.

METHODS: University Health Network’s Centre for Global eHealth Innovation and clinical leads from the University Health Network’s Asthma and Airway Centre worked collaboratively to create an Android application (app) to support self-management in patients with COPD. User-centered design principles were utilized throughout the development process. A technical Working Group (WG) and a clinical WG were engaged to provide input into desired content, features and usability. Patients with COPD were interviewed to gather user requirements and iterative usability testing was performed with patients and clinicians separately.

RESULTS: An app accessible on a smartphone using Android operating system was developed. Features of the app include a tailored list of COPD medications, reminders to aid in adherence to a medication schedule, and links to inhaler technique videos. The app also incorporates daily symptom tracking as a tool for early identification of acute exacerbations of COPD, and prompts users to initiate a customized action plan when an acute exacerbation is identified. Patient-specific data is entered into the app by the clinical team and longitudinal data visualization, including exacerbation history and acute care visits, is available to both patients and clinicians. Usability studies conducted throughout the development of the app validated and strengthened the design, ensuring the development of a usable, useful, and engaging application.

CONCLUSIONS: Mobile information technology has not been widely used to support self-management in COPD patients. This novel app has been designed to help patients with COPD self-manage their condition, and capitalize on “teachable moments” to improve early recognition and response to acute exacerbations.

CLINICAL IMPLICATIONS: Mobile information technology provides an innovative approach to supporting selected patients with COPD. This app could be integrated into clinical work flows to support and enhance existing clinical care. A six-month pilot project of the app is to be completed in 2015.

DISCLOSURE: The following authors have nothing to disclose: Yeung Melanie, Joseph Cafazzo, Emily Seto, Kenneth Chapman, Deborah Casey

The application for COPD self-management that has been developed is still being evaluated for feasibility and impact. The application is currently being piloted in a clinical setting, with plans for larger implementation and evaluation next year. At present, the app is only available through participation in the pilot and is not available to the general public for download or use.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543